Piperidylmethyl-substituted chroman derivatives

Details Piperidylmethyl-substituted chroman derivatives Piperidylmethyl-substituted chroman derivatives

1992-11-30

1994-07-05

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514320, 546187, 546196, 546206, A61K 31445, C07D40506, C07D40514

Patent

active

053267710

ABSTRACT:
Piperidylmethyl-substituted chroman derivatives can be prepared by first reducing corresponding chromancarboxylic acid derivatives, if appropriate with prior activation, with the cyclic amines and then reducing the carbonyl group, or by reacting chromanmethyl compounds directly with the cyclic amines. The substituted piperidylmethyl-substituted chroman derivatives can be employed as active compounds in medicaments, in particular for the treatment of diseases of the central-nervous system.

REFERENCES:
patent: 3759927 (1973-09-01), Huebner
patent: 3826835 (1974-07-01), Huebner
patent: 3845060 (1974-10-01), Huebner
patent: 4376123 (1983-03-01), Hausberg et al.
patent: 4745114 (1988-05-01), Elliott et al.
patent: 4957928 (1990-09-01), Frostl et al.
patent: 5112855 (1992-05-01), Frostl et al.
patent: 5137901 (1992-08-01), Junge et al.
J. Med. Chem. 22 (6) 539-544, 1986.
Eur. J. Med. Chem. 22 (6) 539-544, 1987.
Farmaco, Ed. Sci. 42 (11) 805-813, 1989.
Aldrichimica Acta 18, 25, 1985.
Still et al, J. Org. Chem. 43, 2923, 1978.

Affiliated with

Also associated with

Rating

Piperidylmethyl-substituted chroman derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperidylmethyl-substituted chroman derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidylmethyl-substituted chroman derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-796163